You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Evaluations allow patients to try InterStim™ therapy to assess its effectiveness so they can make an educated decision with their physician about whether to proceed with implantation. In general, the evaluation is successful if the patient experiences a significant (50% or greater) reduction in symptoms.
The basic evaluation (also referred to as peripheral nerve evaluation or PNE) is typically used to evaluate patients with bladder control and bowel control problems. It is initiated through a simple procedure, during which the lead is placed in the upper buttock.
This lead connects to an external neurostimulator (ENS) that the patient wears on a belt. For up to 7 days (depending on physician guidance), the patient completes a symptom diary that is eventually compared to a baseline (established by using a symptom diary prior to the evaluation).1
The advanced evaluation (also referred to as Stage 1) is initiated through an outpatient procedure performed in a hospital or surgical centre.
The patient also wears an ENS during the advanced evaluation, which lasts up to 28 days (depending on physician guidance). Symptom diaries are used to measure results.
Complications can occur with the evaluation, including movement of the wire, technical problems with the device, and some temporary pain. Patients should be instructed on operating the test device and given other precautions related to the evaluation as well as activity restrictions.
Goldman et al. International Continence Society best practice statement for use of sacral neuromodulation; Neurourology and Urodynamics 2018;1-26
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. If using an MRI SureScan® device, see the MRI SureScan® technical manual before performing an MRI. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu website
For applicable products, consult instructions for use on www.medtronic.com/manuals.
Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.